Ovarian Cancer | Tumor

The Future of Ovarian Cancer: PARP Inhibition 'Leading the Way'

July 6th 2018

PARP inhibitors have made for new and exciting treatment options for ovarian cancer, but there is still much more work to be done, according to Dennis J. Slamon, M.D., Ph.D.

Examining Early-Life Adversity and the 'Stress Hormone' in Ovarian Cancer Survivors

July 3rd 2018

Adversity early on in life and increased stress levels could impact ovarian cancer outcomes – even if these instances happen before a woman is diagnosed, according to a recent article published in the journal Cancer.

CURE's Top 5 Stories: June 2018

July 2nd 2018

Take a look at the top five CURE stories of June 2018 in this video.

Lynparza Prolongs Disease Progression in Advanced Ovarian Cancer

June 29th 2018

PARP inhibitors continue to impress in the ovarian cancer space, as findings from the recent phase 3 SOLO-1 trial showed that Lynparza (olaparib) showed clinically-meaningful improvement in progression-free survival (PFS) when used in the first-line maintenance setting.

Exploring Another Biomarker in Ovarian Cancer

June 26th 2018

Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.

Majority of Women With Ovarian Cancer Feel Uncomfortable Raising Psychological Concerns

June 25th 2018

A recent review of data found that 79 percent of patients with ovarian cancer felt uncomfortable raising psychological and emotional concerns during their consultations.

Zejula Shows Potential as More Than Just Maintenance Therapy

June 24th 2018

In the QUADRA study, treatment with Zejula (niraparib) demonstrated durable responses among women with relapsed or refractory ovarian cancer, regardless of BRCA mutation.

Testing Only the 'Tip of the Iceberg' for Common Hereditary Condition in MSI-H Tumors

June 14th 2018

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

FDA Approves Avastin Regimen for Ovarian Cancer Treatment

June 13th 2018

The Food and Drug Administration approved a combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with advanced ovarian cancer who have had surgical resection.

FDA Approves Paxman Cooling Cap for Solid Tumors

June 12th 2018

The FDA approved the Paxman Scalp Cooling System for patients with solid tumors who wish to prevent chemotherapy-related hair loss.

Genetic Testing: The 'Train That Keeps On Chugging'

June 5th 2018

Although genetic testing could be crucial in developing treatment plans and improving outcomes in women with ovarian and breast cancer, less than 20 percent of eligible patients actually get tested, according to Mike Janicek, M.D.

Expert Discusses the Evolving Field of Gynecologic Cancers

June 5th 2018

The field of ovarian cancer is changing rapidly, and moving toward an era of precision medicine.

A Brave, BeauTEALful Warrior

June 4th 2018

Sound Affects Seeks to Change Fight, Finances of War on Cancer

June 1st 2018

While many advocacy groups set out to raise money for cancer research, a first-of-its-kind charitable crowdfunding platform, called Sound Affects, has set out to change how the war on cancer is fought and financed, all with support from musical talents.

PARP Inhibitors Continue to Impress in the Ovarian Cancer Space

May 31st 2018

There are now three PARP inhibitors approved for the treatment of ovarian cancer, improving outcomes of many of the women who take them.

Neoadjuvant Therapy Becoming More Popular in Ovarian Cancer Treatment

May 30th 2018

Paradigms are shifting in the way that ovarian cancer is being treated.

Memories of Cancer on Memorial Day

May 28th 2018

Memorial Day has multiple meanings for this cancer survivor.

Putting a Face to Ovarian Cancer

May 7th 2018

Survivors teach medical and nursing students around the world about early disease signs and symptoms.

Lifting Barbells and Women's Spirits: Girls Gone Rx Puts Focus on Cancer Fundraising

May 3rd 2018

Girls Gone Rx sponsors all-female fitness competitions to raise money for Bright Pink, a nonprofit that focuses on prevention and early detection of breast and ovarian cancer.

Palliative Care Just as Important as Treating Ovarian Cancer Itself

May 3rd 2018

Palliative care can be used at all cancer stages, and can drastically improve patients' quality of life.

Tumor Testing Accelerates Process to 'Conquer Final Frontier' in Ovarian Cancer

May 2nd 2018

With the number of treatment options consistently increasing, tumor testing is growing more important to personalize care for women with ovarian cancer.

Ovarian Cancer Storytellers Help Women Find Their Voice

May 1st 2018

An evening of storytelling among women afflicted by ovarian cancer – whether it be their own diagnosis or a loved one’s – helped to empower individuals to find their voice.

'Teal Army' Heroes

April 26th 2018

Hear from our four Ovarian Cancer Heroes about what inspires them in the fight against the disease.

Making Metastatic Cancer Fears Work for Me

April 24th 2018

So, what was the first thing I thought about when I vowed to not think about cancer? Cancer, of course.

FDA Approves First Assay to Identify Rubraca Benefit Among Women with Ovarian Cancer

April 24th 2018

The Food and Drug Administration (FDA) approved a next-generation sequencing (NGS) companion diagnostic assay that can detect BRCA1/2 genetic mutations, as well as the percentage of genomic loss of heterozygosity (LOH) in patients with ovarian cancer.

23andMe Test Opens Conversations, Highlights Need for Genetic Counselors

April 23rd 2018

Albeit growing popularity of at-home genetic testing, it is still necessary to seek professional medical opinions from genetic counselors to help discuss results.

Debunking Clinical Trial Myths

April 23rd 2018

Many patients with ovarian cancer have misconceptions about the care they will receive while on a clinical trial, according to Laurel W. Rice, M.D.

Patrick Dempsey on Complementary Therapies

April 17th 2018

Yoga and Reiki can have great benefits for patients undergoing cancer treatment, according to Patrick Dempsey.

A Candid Conversation With Patrick Dempsey

April 12th 2018

Patrick Dempsey, actor, cancer advocate and Breakaway From Cancer® Ambassador, sat down with CURE® to discuss how cancer impacted his life after his mother was diagnosed with ovarian cancer.

Thinking Outside Cancer's Box

April 11th 2018

Cancer is a serious business. But who said it needs to be a business of seriousness?